Drug Type Recombinant protein |
Synonyms MT 66, MT66 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Homocysteinemia | Preclinical | China | 01 Nov 2024 | |
| Hypermethioninemia | Preclinical | China | 01 Nov 2024 | |
| Neoplasms | Preclinical | China | 01 Nov 2024 | |
| Obesity | Preclinical | China | 01 Nov 2024 |






